Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
1 NEW September 25, 2023
Prolonged viral prophylaxis helps limit reactivation events after cord blood transplantation

Prolonged viral prophylaxis helps limit reactivation events after cord blood transplantation

From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
Science SpotlightMay 18, 2020
Bezos family gives $35 million to Fred Hutch

Bezos family gives $35 million to Fred Hutch

Transformative investment will be used to hire more world-class researchers to launch innovative approaches to curing cancer, said Fred Hutch President and Director Gilliland
News ReleasesMarch 30, 2017
'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies

'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies

New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein
Hutch NewsDecember 03, 2015
A pioneering procedure’s expanding influence

A pioneering procedure’s expanding influence

Developed to treat leukemia, stem cell transplants gave rise to new therapies for an ever-growing number of patients and conditions
Hutch NewsAugust 01, 2015
Gratitude, guilt and surviving cancer

Gratitude, guilt and surviving cancer

<p>Living through cancer is life-changing — often in unimagined and challenging ways, says leukemia survivor Jessie Quinn</p>
Hutch NewsJanuary 26, 2015